Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04203537 · ClinicalTrials.gov registry record · Phase 1
Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin)
A Phase 1 study, sponsored by Concentric Analgesics.
- Completed
- Registry status
- Phase 1
- Development phase
- 193
- Enrollment target
NCT04203537 is a Phase 1 study that has completed, run by Concentric Analgesics. The registered enrollment target is 193 participants.
The verdict
NCT04203537, a Phase 1 study, has completed, sponsored by Concentric Analgesics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 193 participants
- Enrollment target
Study Summary
In the pilot (Part A) of this study, multiple doses of CA-008 (vocacapsaicin) were evaluated for safety, tolerability, and PK. Doses were then selected for the expanded part (Part B) of the study, where CA-008 was compared to placebo. Patients had serial assessments of safety, PK, and drug effect.
Interventions
- DRUG Placebo
- DRUG CA-008
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2019-12-04 |
| Est. Completion | 2020-10-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04203537
The ClinicalTrials.gov registry entry for NCT04203537 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Concentric Analgesics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04203537 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04203537 about?
NCT04203537 is a clinical study titled "Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin)". In the pilot (Part A) of this study, multiple doses of CA-008 (vocacapsaicin) were evaluated for safety, tolerability, and PK. Doses were then selected for the expanded part (Part B) of the study, where CA-008 was compared to placebo. Patients had serial assessments of safety, PK, and drug effect.
What is the current status of trial NCT04203537?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 193 participants. The study started on 2019-12-04. Estimated completion is 2020-10-26.
What interventions are being tested in trial NCT04203537?
The interventions under investigation include: Placebo (DRUG), CA-008 (DRUG).
Who is sponsoring clinical trial NCT04203537?
This trial is sponsored by Concentric Analgesics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.